Titulo:

.

Guardado en:

0121-5426

2538-9513

25

2016-12-04

Revista Colombiana de Neumología - 2016

info:eu-repo/semantics/openAccess

http://purl.org/coar/access_right/c_abf2

id metarevistapublica_asoneumocito_revistacolombianadeneumologia_28_article_120
record_format ojs
spelling Pulmonary proteinosis is a rare pulmonary condition in which there is a disbalance between the production and elimination of alveolar surfactant resulting in the accumulation of lipoproteinaceous material within the alveoli. The majority of cases are caused by production of antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) with secondary dysfunction of the alveolar macrophage and accumulation of surfactant. Nontheless there is a non-autoimmune presentation which includes the congenital and the secondary type. It has a variable course ranging from ventilatory failure to complete resolution and it predisposes to pulmonary infections. The diagnosis is based on radiologic findings in presence of positive PAS stain on the bronchoalveolar lavage. The treatment options were previously based on whole lung lavage (WLL), however other modalities of treatment have been described including Rituximab, Plasmapheresis and GM-CSF replacement. We present a case of alveolar proteinosis and review the therapeutic options for 2013.
Kattah, MD., Laura
Londoño, MD., Darío
pulmonary alveolar proteinosis
granulocyte-macrophage colony-stimulating factor
proteinosis alveolar
factor estimulante de colonias de macrófagos y monocitos
rituximab
25
2
Artículo de revista
Journal article
2016-12-04T00:00:00Z
2016-12-04T00:00:00Z
2016-12-04
application/pdf
Asociación Colombiana de Neumología y Cirugía de Tórax
Revista Colombiana de Neumología
0121-5426
2538-9513
https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/120
10.30789/rcneumologia.v25.n2.2013.120
https://doi.org/10.30789/rcneumologia.v25.n2.2013.120
spa
https://creativecommons.org/licenses/by-nc-sa/4.0/
Revista Colombiana de Neumología - 2016
https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/120/114
info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_dcae04bc
http://purl.org/redcol/resource_type/ARTREV
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
Text
Publication
institution ASOCIACION COLOMBIANA DE NEUMOLOGIA Y CIRUGIA DE TORAX
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADENEUMOLOGIAYCIRUGIADETORAX/logo.png
country_str Colombia
collection Revista Colombiana de Neumología
description_eng Pulmonary proteinosis is a rare pulmonary condition in which there is a disbalance between the production and elimination of alveolar surfactant resulting in the accumulation of lipoproteinaceous material within the alveoli. The majority of cases are caused by production of antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) with secondary dysfunction of the alveolar macrophage and accumulation of surfactant. Nontheless there is a non-autoimmune presentation which includes the congenital and the secondary type. It has a variable course ranging from ventilatory failure to complete resolution and it predisposes to pulmonary infections. The diagnosis is based on radiologic findings in presence of positive PAS stain on the bronchoalveolar lavage. The treatment options were previously based on whole lung lavage (WLL), however other modalities of treatment have been described including Rituximab, Plasmapheresis and GM-CSF replacement. We present a case of alveolar proteinosis and review the therapeutic options for 2013.
author Kattah, MD., Laura
Londoño, MD., Darío
spellingShingle Kattah, MD., Laura
Londoño, MD., Darío
pulmonary alveolar proteinosis
granulocyte-macrophage colony-stimulating factor
proteinosis alveolar
factor estimulante de colonias de macrófagos y monocitos
rituximab
author_facet Kattah, MD., Laura
Londoño, MD., Darío
topic pulmonary alveolar proteinosis
granulocyte-macrophage colony-stimulating factor
proteinosis alveolar
factor estimulante de colonias de macrófagos y monocitos
rituximab
topic_facet pulmonary alveolar proteinosis
granulocyte-macrophage colony-stimulating factor
proteinosis alveolar
factor estimulante de colonias de macrófagos y monocitos
rituximab
topicspa_str_mv proteinosis alveolar
factor estimulante de colonias de macrófagos y monocitos
rituximab
citationvolume 25
citationissue 2
publisher Asociación Colombiana de Neumología y Cirugía de Tórax
ispartofjournal Revista Colombiana de Neumología
source https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/120
language spa
format Article
rights https://creativecommons.org/licenses/by-nc-sa/4.0/
Revista Colombiana de Neumología - 2016
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2016-12-04
date_accessioned 2016-12-04T00:00:00Z
date_available 2016-12-04T00:00:00Z
url https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/120
url_doi https://doi.org/10.30789/rcneumologia.v25.n2.2013.120
issn 0121-5426
eissn 2538-9513
doi 10.30789/rcneumologia.v25.n2.2013.120
url2_str_mv https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/120/114
_version_ 1811200695714447360